Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001641172-25-025041
Filing Date
2025-08-21
Accepted
2025-08-21 08:30:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B4 form424b4.htm 424B4 3896266
2 GRAPHIC form424b4_001.jpg GRAPHIC 23623
  Complete submission text file 0001641172-25-025041.txt   3930123
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-289670 | Film No.: 251238461
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)